Bafna Pharmaceuticals has informed that it has enclosed voting results for the Annual General Meeting (AGM) held on 31st July 2020 under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and scrutinizer report.
The above information is a part of company’s filings submitted to BSE.